GlassScriptPhysician profile
Jason C Berry
NPI 1598742710
$5,480.86
in general payments reported to CMS, 2019-2025
41 companies · $912 in 2025
The $912 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,131 · 2020: $27.70 · 2021: $717 · 2022: $898 · 2023: $796 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.18 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,048.95 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $658.16 | 2019-2023 | Mounjaro, Emgality |
| Amgen INC. | $519.49 | 2019-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $426.71 | 2019-2025 | Airsupra, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $322.49 | 2019-2022 | |
| Antares Pharma, INC. | $319.50 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $262.54 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $252.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.26 | 2019-2025 | Jardiance, Synjardy |
| Abbott Laboratories | $110.71 | 2022-2023 | Freestyle Libre 3 |
| Abbvie INC. | $103.64 | 2023-2025 | Vraylar |
| Biohaven Pharmaceuticals, INC. | $103.31 | 2021 | |
| Sanofi-Aventis U.S. LLC | $100.75 | 2019-2025 | |
| Glaxosmithkline, LLC. | $85.65 | 2019-2023 | Trelegy Ellipta |
| Radius Health, INC. | $85.49 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.